Literature DB >> 15454257

Standard cancer patient population for age standardising survival ratios.

Isabella Corazziari1, Mike Quinn, Riccardo Capocaccia.   

Abstract

Standard adult cancer patients populations are derived in this paper as a tool for the calculation of age-standardised cancer survival figures. Previously used standards in survival analysis have been site- and/or study-specific. Here, multivariate methods have been used to define the smallest possible number of general standard cancer patient populations which are simple to use and provide standardised survival values close to the raw ones for the largest possible number of cancer sites. The analysis was based on data for over 1.1 million cancer patients included in the EUROCARE-2 study. The proposed standard populations consist of three age distributions, appropriate for cancers with incidence patterns: (1) increasing with age - the vast majority of cancers; (2) broadly constant with age and (3) mainly affecting young adults. The three standard distributions are presented by both broad and five-year age classes. The latter can be used to determine which of the three standards would be used for sites not included in the cluster analysis because their survival is generally calculated in unusual age groups. Overall, standard 1 is appropriate for over 91% of cases, standard 2 for just over 7%, and standard 3 for less than 2%. The proposed standards were tested on European (EUROCARE-2 and EUROCARE-3) and US (Surveillance, Epidemiology and End Results Program, SEER) relative survival data. There was very good correspondence between the raw (population weighted) and age-standardised survival figures.

Entities:  

Mesh:

Year:  2004        PMID: 15454257     DOI: 10.1016/j.ejca.2004.07.002

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  147 in total

1.  Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.

Authors:  Nadia Howlader; Lindsay M Morton; Eric J Feuer; Caroline Besson; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-15       Impact factor: 4.254

2.  Disparate survival trends in histologic subtypes of metastatic non-small cell lung cancer: a population-based analysis.

Authors:  Adam J Olszewski; Shihab Ali; Sabrina M Witherby
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

3.  German cancer statistics 2004.

Authors:  Jörg Haberland; Joachim Bertz; Ute Wolf; Thomas Ziese; Bärbel-Maria Kurth
Journal:  BMC Cancer       Date:  2010-02-22       Impact factor: 4.430

4.  Cancer survival in adult patients in Spain. Results from nine population-based cancer registries.

Authors:  M D Chirlaque; D Salmerón; J Galceran; A Ameijide; A Mateos; A Torrella; R Jiménez; N Larrañaga; R Marcos-Gragera; E Ardanaz; M Sant; P Minicozzi; C Navarro; M J Sánchez
Journal:  Clin Transl Oncol       Date:  2017-07-17       Impact factor: 3.405

5.  Female breast cancer in Gipuzkoa: prognostic factors and survival.

Authors:  N Larrañaga; C Sarasqueta; P Martínez-Camblor; M J Mitxelena; A Mendiola; I Martínez-Pueyo; M Basterretxea
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

6.  Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Authors:  Claudia Allemani; Tomohiro Matsuda; Veronica Di Carlo; Rhea Harewood; Melissa Matz; Maja Nikšić; Audrey Bonaventure; Mikhail Valkov; Christopher J Johnson; Jacques Estève; Olufemi J Ogunbiyi; Gulnar Azevedo E Silva; Wan-Qing Chen; Sultan Eser; Gerda Engholm; Charles A Stiller; Alain Monnereau; Ryan R Woods; Otto Visser; Gek Hsiang Lim; Joanne Aitken; Hannah K Weir; Michel P Coleman
Journal:  Lancet       Date:  2018-01-31       Impact factor: 79.321

7.  Cancer incidence and survival among Métis adults in Canada: results from the Canadian census follow-up cohort (1992-2009).

Authors:  Maegan V Mazereeuw; Diana R Withrow; E Diane Nishri; Michael Tjepkema; Eduardo Vides; Loraine D Marrett
Journal:  CMAJ       Date:  2018-03-19       Impact factor: 8.262

8.  Methodological issues in estimating survival in patients with multiple primary cancers: an application to women with breast cancer as a first tumour.

Authors:  Stefano Rosso; Fulvio Ricceri; Lea Terracini; Roberto Zanetti
Journal:  Emerg Themes Epidemiol       Date:  2009-02-27

9.  A visual summary of the EUROCARE-4 results: a UK perspective.

Authors:  H Møller; K M Linklater; D Robinson
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

10.  Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?

Authors:  C S Thomson; D Forman
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.